"unique_sample_molecule_ch1","unique_sample_molecule_ch2","unique_sample_source_name_ch1","unique_sample_status","unique_sample_library_selection","unique_sample_library_source","unique_sample_extract_protocol_ch1","unique_sample_extract_protocol_ch2","unique_sample_label_protocol_ch1","unique_sample_source_name_ch2","unique_sample_library_strategy","unique_sample_characteristics_ch2","unique_sample_label_protocol_ch2","unique_sample_label_protocol","unique_sample_series_id","unique_sample_data_processing","unique_sample_description","unique_sample_characteristics_ch1","unique_sample_organism_ch1","unique_tissue","unique_sample_type","unique_sample_title","unique_sample_name","unique_sample_hyb_protocol","unique_sample_label_ch2","unique_disease_state","unique_ethnicity","unique_time_point","unique_tmprss2","unique_treatment","unique_cancer_status","unique_tissuer_type","unique_tumor_type","unique_age","unique_gleason_score","unique_pathologic_tumor_stage","unique_gleason_grade","unique_t.stage","unique_margin_status","unique_preop_psa","unique_bcr","unique_bcr_free_time","total_samples"
"total RNA","NA","prostate biopsy from prostate cancer patient","Public on Jul 27 2015,Public on Aug 07 2015","NA","NA","RNA was prepared using the miRNeasy kit (Qiagen, Valencia, CA) following the manufacturer's recommendations. The protocol includes dhomogenization of prostate biopsy samples, and an on-column DNase digestion. RNA was quantified using a NanoDrop-1000 spectrophotometer and quality was monitored with the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA).,All RNA samples were purified by using Qiagen RNeasy micro kit (Qiagen). Samples were then treated with the RiobMinus, rRNA reduction kit (Invitrogen), cDNA synthesis and amplification was performed using the WT cDNA synthesis and amplification kit (Affymetrix).","NA","Cyanine-3 (Cy3) labeled cRNA was prepared from 250 ng RNA using Agilent's miRNA Complete Labeling according to the manufacturer's instructions. T4 RNA ligase and Cy-3-pCp were used for labeling the miRNA samples. The labeled RNA samples were purified by Micro Bio-Spin 6 column.,Samples were enzymatically fragmented and biotinylated using the WT Terminal Labeling Kit (Affymetrix)","NA","NA","NA","NA","NA","GSE64318, GSE64333,GSE64331, GSE64333,GSE64333, GSE71781,GSE64333, GSE71783","The scanned images were analyzed with Feature Extraction Software 9.5.3 (Agilent) using default parameters for miRNA array to obtain background subtracted and spatially detrended Processed Signal intensities.  The feature extraction files were imported to Agilent's Genespring program for data analysis. The quantile normalization and log2 transformation was applied to get the normalized data accross the 56 arrays.,Data were processed using Partek Genomics Suite software. Quantile normalization and GC-RMA background correction were applied to probe intensities, gene level expression were summarized from the corrected/normalized intensities. Only core probe sets were used for data analysis., HuEx-1_0-st-v2.r2.pgf","NA","NA","Homo sapiens","prostate cancer samples from AA,prostate cancer samples from EA,patient matched normal tissue from AA,patient matched normal tissue from EA,prostate","RNA","AA cancer 1 [Agilent],AA cancer 2 [Agilent],AA cancer 3 [Agilent],AA cancer 4 [Agilent],EA cancer 1 [Agilent],EA cancer 2 [Agilent],EA cancer 3 [Agilent],EA cancer 4 [Agilent],AA cancer 5 [Agilent],AA cancer 6 [Agilent],AA cancer 7 [Agilent],AA cancer 8 [Agilent],EA cancer 5 [Agilent],EA cancer 6 [Agilent],EA cancer 7 [Agilent],EA cancer 8 [Agilent],AA normal 1 [Agilent],AA normal 2 [Agilent],AA normal 3 [Agilent],AA normal 4 [Agilent],EA normal 1 [Agilent],EA normal 2 [Agilent],EA normal 3 [Agilent],EA normal 4 [Agilent],AA normal 5 [Agilent],AA normal 6 [Agilent],AA normal 7 [Agilent],AA normal 8 [Agilent],EA normal 5 [Agilent],EA normal 6 [Agilent],EA normal 7 [Agilent],EA normal 8 [Agilent],AA tumor 9 [Agilent],AA tumor 11 [Agilent],AA tumor 12 [Agilent],EA tumor 9 [Agilent],EA tumor 10 [Agilent],EA tumor 11 [Agilent],EA tumor 12 [Agilent],AA normal 9 [Agilent],EA normal 10 [Agilent],EA normal 9 [Agilent],AA normal 11 [Agilent],EA normal 11 [Agilent],AA normal 12 [Agilent],EA normal 12 [Agilent],EA normal 13 [Agilent],EA tumor 13 [Agilent],AA normal 13 [Agilent],AA tumor 13 [Agilent],AA normal 14 [Agilent],AA tumor 14 [Agilent],AA normal 15 [Agilent],AA tumor 15 [Agilent],AA tumor 4  [Affymetrix],AA tumor 6 [Affymetrix],EA tumor 9 [Affymetrix],AA tumor 10 [Affymetrix],AA tumor 13 [Affymetrix],EA tumor 15 [Affymetrix],EA tumor 16 [Affymetrix],AA tumor 17 [Affymetrix],EA tumor 18 [Affymetrix],AA tumor 19 [Affymetrix],AA tumor 21 [Affymetrix],EA tumor 28 [Affymetrix],AA tumor 29 [Affymetrix],EA tumor 30 [Affymetrix],AA tumor 32 [Affymetrix],AA tumor 34 [Affymetrix],AA tumor 35 [Affymetrix],AA tumor 43 [Affymetrix],EA tumor 44 [Affymetrix],AA tumor 48 [Affymetrix],AA tumor 49 [Affymetrix],AA tumor 51 [Affymetrix],EA tumor 57 [Affymetrix],EA tumor 58 [Affymetrix],EA tumor 60 [Affymetrix],AA tumor 75 [Affymetrix],AA tumor 84 [Affymetrix],EA tumor 87 [Affymetrix],EA tumor 105 [Affymetrix],AA tumor 106 [Affymetrix],AA tumor 115 [Affymetrix],EA tumor 121 [Affymetrix],EA tumor 124 [Affymetrix],EA tumor 139 [Affymetrix],AA tumor 155 [Affymetrix],AA_tumor_4 [reanalysis Affymetrix],AA_normal_4 [Affymetrix],AA_tumor_6 [reanalysis Affymetrix],AA_normal_6 [Affymetrix],AA_tumor_10 [reanalysis Affymetrix],AA_normal_10 [Affymetrix],AA_tumor_13 [reanalysis Affymetrix],AA_normal_13 [Affymetrix],AA_tumor_17 [reanalysis Affymetrix],AA_normal_17 [Affymetrix],AA_tumor_19 [reanalysis Affymetrix],AA_normal_19 [Affymetrix],AA_tumor_21 [reanalysis Affymetrix],AA_normal_21 [Affymetrix],AA_normal_29 [Affymetrix],AA_tumor_29 [reanalysis Affymetrix],AA_normal_32 [Affymetrix],AA_tumor_32 [reanalysis Affymetrix],AA_normal_34 [Affymetrix],AA_tumor_34 [reanalysis Affymetrix],AA_normal_35 [Affymetrix],AA_tumor_35 [reanalysis Affymetrix],AA_normal_43 [Affymetrix],AA_tumor_43 [reanalysis Affymetrix],AA_tumor_48 [reanalysis Affymetrix],AA_normal_48 [Affymetrix],AA_tumor_49 [reanalysis Affymetrix],AA_normal_49 [Affymetrix],AA_tumor_51 [reanalysis Affymetrix],AA_normal_51 [Affymetrix],AA_tumor_75 [reanalysis Affymetrix],AA_normal_75 [Affymetrix],AA_tumor_84 [reanalysis Affymetrix],AA_normal_84 [Affymetrix],AA_tumor_106 [reanalysis Affymetrix],AA_normal_106 [Affymetrix],AA_tumor_120 [Affymetrix],AA_normal_120 [Affymetrix],AA_tumor_155 [reanalysis Affymetrix],AA_normal_155 [Affymetrix],EA normal 9 [Affymetrix],EA tumor 9 [reanalysis Affymetrix],EA tumor 15 [reanalysis Affymetrix],EA normal 15 [Affymetrix],EA normal 16 [Affymetrix],EA tumor 16 [reanalysis Affymetrix],EA tumor 18 [reanalysis Affymetrix],EA normal 18 [Affymetrix],EA normal 28 [Affymetrix],EA tumor 28 [reanalysis Affymetrix],EA tumor 30 [reanalysis Affymetrix],EA normal 30 [Affymetrix],EA tumor 44 [reanalysis Affymetrix],EA normal 44 [Affymetrix],EA tumor 57 [reanalysis Affymetrix],EA normal 57 [Affymetrix],EA tumor 58 [reanalysis Affymetrix],EA normal 58 [Affymetrix],EA tumor 60 [reanalysis Affymetrix],EA normal 60 [Affymetrix],EA tumor 87 [reanalysis Affymetrix],EA normal 87 [Affymetrix],EA tumor 105 [reanalysis Affymetrix],EA normal 105 [Affymetrix],EA tumor 121 [reanalysis Affymetrix],EA normal 121 [Affymetrix],EA tumor 124 [reanalysis Affymetrix],EA normal 124 [Affymetrix],EA tumor 139 [reanalysis Affymetrix],EA normal 139 [Affymetrix]","aa_cancer_1_agilent_,aa_cancer_2_agilent_,aa_cancer_3_agilent_,aa_cancer_4_agilent_,ea_cancer_1_agilent_,ea_cancer_2_agilent_,ea_cancer_3_agilent_,ea_cancer_4_agilent_,aa_cancer_5_agilent_,aa_cancer_6_agilent_,aa_cancer_7_agilent_,aa_cancer_8_agilent_,ea_cancer_5_agilent_,ea_cancer_6_agilent_,ea_cancer_7_agilent_,ea_cancer_8_agilent_,aa_normal_1_agilent_,aa_normal_2_agilent_,aa_normal_3_agilent_,aa_normal_4_agilent_,ea_normal_1_agilent_,ea_normal_2_agilent_,ea_normal_3_agilent_,ea_normal_4_agilent_,aa_normal_5_agilent_,aa_normal_6_agilent_,aa_normal_7_agilent_,aa_normal_8_agilent_,ea_normal_5_agilent_,ea_normal_6_agilent_,ea_normal_7_agilent_,ea_normal_8_agilent_,aa_tumor_9_agilent_,aa_tumor_11_agilent_,aa_tumor_12_agilent_,ea_tumor_9_agilent_,ea_tumor_10_agilent_,ea_tumor_11_agilent_,ea_tumor_12_agilent_,aa_normal_9_agilent_,ea_normal_10_agilent_,ea_normal_9_agilent_,aa_normal_11_agilent_,ea_normal_11_agilent_,aa_normal_12_agilent_,ea_normal_12_agilent_,ea_normal_13_agilent_,ea_tumor_13_agilent_,aa_normal_13_agilent_,aa_tumor_13_agilent_,aa_normal_14_agilent_,aa_tumor_14_agilent_,aa_normal_15_agilent_,aa_tumor_15_agilent_,aa_tumor_4__affymetrix_,aa_tumor_6_affymetrix_,ea_tumor_9_affymetrix_,aa_tumor_10_affymetrix_,aa_tumor_13_affymetrix_,ea_tumor_15_affymetrix_,ea_tumor_16_affymetrix_,aa_tumor_17_affymetrix_,ea_tumor_18_affymetrix_,aa_tumor_19_affymetrix_,aa_tumor_21_affymetrix_,ea_tumor_28_affymetrix_,aa_tumor_29_affymetrix_,ea_tumor_30_affymetrix_,aa_tumor_32_affymetrix_,aa_tumor_34_affymetrix_,aa_tumor_35_affymetrix_,aa_tumor_43_affymetrix_,ea_tumor_44_affymetrix_,aa_tumor_48_affymetrix_,aa_tumor_49_affymetrix_,aa_tumor_51_affymetrix_,ea_tumor_57_affymetrix_,ea_tumor_58_affymetrix_,ea_tumor_60_affymetrix_,aa_tumor_75_affymetrix_,aa_tumor_84_affymetrix_,ea_tumor_87_affymetrix_,ea_tumor_105_affymetrix_,aa_tumor_106_affymetrix_,aa_tumor_115_affymetrix_,ea_tumor_121_affymetrix_,ea_tumor_124_affymetrix_,ea_tumor_139_affymetrix_,aa_tumor_155_affymetrix_,aa_tumor_4_reanalysis_affymetrix_,aa_normal_4_affymetrix_,aa_tumor_6_reanalysis_affymetrix_,aa_normal_6_affymetrix_,aa_tumor_10_reanalysis_affymetrix_,aa_normal_10_affymetrix_,aa_tumor_13_reanalysis_affymetrix_,aa_normal_13_affymetrix_,aa_tumor_17_reanalysis_affymetrix_,aa_normal_17_affymetrix_,aa_tumor_19_reanalysis_affymetrix_,aa_normal_19_affymetrix_,aa_tumor_21_reanalysis_affymetrix_,aa_normal_21_affymetrix_,aa_normal_29_affymetrix_,aa_tumor_29_reanalysis_affymetrix_,aa_normal_32_affymetrix_,aa_tumor_32_reanalysis_affymetrix_,aa_normal_34_affymetrix_,aa_tumor_34_reanalysis_affymetrix_,aa_normal_35_affymetrix_,aa_tumor_35_reanalysis_affymetrix_,aa_normal_43_affymetrix_,aa_tumor_43_reanalysis_affymetrix_,aa_tumor_48_reanalysis_affymetrix_,aa_normal_48_affymetrix_,aa_tumor_49_reanalysis_affymetrix_,aa_normal_49_affymetrix_,aa_tumor_51_reanalysis_affymetrix_,aa_normal_51_affymetrix_,aa_tumor_75_reanalysis_affymetrix_,aa_normal_75_affymetrix_,aa_tumor_84_reanalysis_affymetrix_,aa_normal_84_affymetrix_,aa_tumor_106_reanalysis_affymetrix_,aa_normal_106_affymetrix_,aa_tumor_120_affymetrix_,aa_normal_120_affymetrix_,aa_tumor_155_reanalysis_affymetrix_,aa_normal_155_affymetrix_,ea_normal_9_affymetrix_,ea_tumor_9_reanalysis_affymetrix_,ea_tumor_15_reanalysis_affymetrix_,ea_normal_15_affymetrix_,ea_normal_16_affymetrix_,ea_tumor_16_reanalysis_affymetrix_,ea_tumor_18_reanalysis_affymetrix_,ea_normal_18_affymetrix_,ea_normal_28_affymetrix_,ea_tumor_28_reanalysis_affymetrix_,ea_tumor_30_reanalysis_affymetrix_,ea_normal_30_affymetrix_,ea_tumor_44_reanalysis_affymetrix_,ea_normal_44_affymetrix_,ea_tumor_57_reanalysis_affymetrix_,ea_normal_57_affymetrix_,ea_tumor_58_reanalysis_affymetrix_,ea_normal_58_affymetrix_,ea_tumor_60_reanalysis_affymetrix_,ea_normal_60_affymetrix_,ea_tumor_87_reanalysis_affymetrix_,ea_normal_87_affymetrix_,ea_tumor_105_reanalysis_affymetrix_,ea_normal_105_affymetrix_,ea_tumor_121_reanalysis_affymetrix_,ea_normal_121_affymetrix_,ea_tumor_124_reanalysis_affymetrix_,ea_normal_124_affymetrix_,ea_tumor_139_reanalysis_affymetrix_,ea_normal_139_affymetrix_","Cy3-labelled miRNA samples were hybridized in a reaction volume of 45 µl containing 1x Hi-PRM hybridization buffer and 1x GE blocking agent following the manufacturers instructions. The mixed samples were hybridized to Agilent Human miRNA Microarrays (G4112A) for 20 hours at 55°C in a rotating Agilent hybridization oven.  After hybridization, microarrays were washed 5 minute at room temperature with Gene Expression Wash Buffer 1 (Agilent) and 5 minute with 37°C GE Wash buffer 2 (Agilent), then d ...,Samples were hybridized using Affymetrix hybridization kit materials. Heat cocktails at 99° for 5 minutes, then 42° for 5 minutes centrifuge at max speed for 1 minute. Transfer 200μl of hyb solution to each array, then tape holes and parafilm. Hybridize 16 hours at 45° at 60rpm. Fluidics washing is FS450_0001","NA","NA","NA","NA","NA","NA","NA","NA","NA","NA","NA","NA","NA","NA","NA","NA","NA","NA",159
